“…This method allowed us to evaluate only the local effect of vasodilators on GEA, independent of other grafts and hemodynamic factors. With local application alone, fasudil demonstrates superior vasodilatory effect for internal thoracic artery, 22 radial artery, 16 and GEA, with no hemodynamic changes, no perioperative myocardial infarction, and no vasodilator-related complications. This agent may become the standard vasodilator for arterial graft pretreatment in CABG.…”
Section: Commentmentioning
confidence: 95%
“…20 In patients with intractable coronary vasospasm after CABG not responding to maximum vasodilatory therapy, fasudil treatment markedly ameliorated the conditions. 21 To apply the potent vasodilatory effect of the Rho kinase inhibitor to CABG, we previously investigated the vasodilatory effect of fasudil on human internal thoracic artery 22 and radial artery grafts 16 and showed the superior vasodilating effect of fasudil over papaverine and VG for both grafts. In the present study, we found that fasudil increased GEA GFF more than threefold, also significantly and markedly more potent than papaverine and VG.…”
Objective The gastroepiploic artery (GEA) has been used as an alternative arterial in situ graft for coronary artery bypass grafting (CABG). However, because of the large individual differences and the spastic nature of the GEA, caution has to be exercised during harvesting. We evaluated the usefulness of fasudil, a Rho kinase inhibitor, as a vasodilator for right GEA (RGEA) graft after harvesting, compared with the conventional agents papaverine and verapamil-nitroglycerin. Methods Between June 2009 and January 2013, 30 patients with ischemic heart disease who underwent isolated CABG using RGEA graft were randomly assigned to fasudil (n = 10), papaverine (n = 10), or verapamil-nitroglycerin (n = 10) group. Fasudil (2.67 mmol/L), papaverine (1.0 mmol/L) mixed with heparinized blood, or verapamil-nitroglycerin (30 μmol/L each) was injected intraluminally into the RGEA graft after harvesting. Right GEA graft free flow (GFF), hemodynamic changes, and histopathology of RGEA were evaluated. Results Intraluminal injection of fasudil increased GFF significantly (P < 0.001) and markedly from 41.5 ± 31.5 mL/min at baseline to 149.3 ± 46.7 mL/min after injection. Papaverine increased GFF (P < 0.001) from 40.0 ± 35.8 to 64.9 ± 33.7 mL/min, and verapamil-nitroglycerin also increased GFF (P < 0.001) from 38.8 ± 32.1 to 79.0 ± 35.2 mL/min. The GFF was significantly higher (P = 0.001) in the fasudil group than in the other two groups. Histopathologically, fasudil treatment markedly increased the diameter of RGEA graft, while maintaining integrity of the multiple elastic lamellae. Blood pressure did not change significantly after drug injection in all groups. Conclusions Fasudil is more potent than papaverine or verapamilnitroglycerin in increasing GFF of RGEA graft for CABG.
“…This method allowed us to evaluate only the local effect of vasodilators on GEA, independent of other grafts and hemodynamic factors. With local application alone, fasudil demonstrates superior vasodilatory effect for internal thoracic artery, 22 radial artery, 16 and GEA, with no hemodynamic changes, no perioperative myocardial infarction, and no vasodilator-related complications. This agent may become the standard vasodilator for arterial graft pretreatment in CABG.…”
Section: Commentmentioning
confidence: 95%
“…20 In patients with intractable coronary vasospasm after CABG not responding to maximum vasodilatory therapy, fasudil treatment markedly ameliorated the conditions. 21 To apply the potent vasodilatory effect of the Rho kinase inhibitor to CABG, we previously investigated the vasodilatory effect of fasudil on human internal thoracic artery 22 and radial artery grafts 16 and showed the superior vasodilating effect of fasudil over papaverine and VG for both grafts. In the present study, we found that fasudil increased GEA GFF more than threefold, also significantly and markedly more potent than papaverine and VG.…”
Objective The gastroepiploic artery (GEA) has been used as an alternative arterial in situ graft for coronary artery bypass grafting (CABG). However, because of the large individual differences and the spastic nature of the GEA, caution has to be exercised during harvesting. We evaluated the usefulness of fasudil, a Rho kinase inhibitor, as a vasodilator for right GEA (RGEA) graft after harvesting, compared with the conventional agents papaverine and verapamil-nitroglycerin. Methods Between June 2009 and January 2013, 30 patients with ischemic heart disease who underwent isolated CABG using RGEA graft were randomly assigned to fasudil (n = 10), papaverine (n = 10), or verapamil-nitroglycerin (n = 10) group. Fasudil (2.67 mmol/L), papaverine (1.0 mmol/L) mixed with heparinized blood, or verapamil-nitroglycerin (30 μmol/L each) was injected intraluminally into the RGEA graft after harvesting. Right GEA graft free flow (GFF), hemodynamic changes, and histopathology of RGEA were evaluated. Results Intraluminal injection of fasudil increased GFF significantly (P < 0.001) and markedly from 41.5 ± 31.5 mL/min at baseline to 149.3 ± 46.7 mL/min after injection. Papaverine increased GFF (P < 0.001) from 40.0 ± 35.8 to 64.9 ± 33.7 mL/min, and verapamil-nitroglycerin also increased GFF (P < 0.001) from 38.8 ± 32.1 to 79.0 ± 35.2 mL/min. The GFF was significantly higher (P = 0.001) in the fasudil group than in the other two groups. Histopathologically, fasudil treatment markedly increased the diameter of RGEA graft, while maintaining integrity of the multiple elastic lamellae. Blood pressure did not change significantly after drug injection in all groups. Conclusions Fasudil is more potent than papaverine or verapamilnitroglycerin in increasing GFF of RGEA graft for CABG.
“…After relieving the spasm, it is important to maintain the vessel patency by administering dilators and avoiding constrictors. Here is a list of drugs that cause IMA dilation: sodium nitroprusside [21], organic nitrates [38], calcium channel blockers [4] [52], 17beta-estradiol (evidence only for females) [39], natriuretic peptides [40], low molecular weight heparin [41], alpha-adrenergic blockers (in benign prostate hyperplasia), resveratrol [42], iloprost [43], fasudil [44].…”
The article is dedicated to the management of internal mammary artery spasm intra-and postoperatively based on the accumulated evidence in the literature. It provides a stepwise decision algorithm for safely resolving the spasm and prevention of relapse.
“…A more recent study compared the antispastic effect of the commonly used vasodilator, papaverine, with the Rho-kinase inhibitor, fasudil, on free flow following intraluminal injection in the isolated ITA ( 8 ). Fasudil exhibited a very potent vasodilatory effect compared with conventional papaverine.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.